BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24215200)

  • 1. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences.
    Duprez D; Toleuova A
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1725-33. PubMed ID: 24215200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehypertension: the rationale for early drug therapy.
    Fuchs FD
    Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prehypertension - time to act.
    Gupta P; Nagaraju SP; Gupta A; Mandya Chikkalingaiah KB
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):223-33. PubMed ID: 22382212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it time to target prehypertension.
    Whaley-Connell A; Sowers JR
    Cardiovasc Ther; 2010 Dec; 28(6):337-8. PubMed ID: 21050419
    [No Abstract]   [Full Text] [Related]  

  • 5. Prehypertension: an opportunity for a new public health paradigm.
    Egan BM; Lackland DT; Jones DW
    Cardiol Clin; 2010 Nov; 28(4):561-9. PubMed ID: 20937441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand.
    Pongwecharak J; Treeranurat T
    J Am Pharm Assoc (2003); 2011; 51(6):719-26. PubMed ID: 22068193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
    Gaddam KK; Ventura H; Lavie CJ
    Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with prehypertension - do we have enough evidence to treat them?
    Marta M; Zanchetti A; Wong ND; Malyszko J; Rysz J; Banach M
    Curr Vasc Pharmacol; 2014; 12(4):586-97. PubMed ID: 23627984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating prehypertension: medically sound and economically viable.
    Kiely AE; Kwatra SG; Kwatra MM
    Blood Press; 2009; 18(6):300-3. PubMed ID: 19958077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prehypertension and risk of cardiovascular disease.
    Atilla K; Vasan RS
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):111-7. PubMed ID: 16375633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of pre-hypertension and metabolic syndrome.
    Rossi R; Nuzzo A; Modena MG
    Minerva Cardioangiol; 2009 Dec; 57(6):723-31. PubMed ID: 19942844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prehypertension: should we be treating with pharmacologic therapy?
    Egan BM; Nesbitt SD; Julius S
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):305-14. PubMed ID: 19124429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control.
    Gupta R; Deedwania PC; Achari V; Bhansali A; Gupta BK; Gupta A; Mahanta TG; Asirvatham AJ; Gupta S; Maheshwari A; Saboo B; Jali MV; Singh J; Guptha S; Sharma KK
    Am J Hypertens; 2013 Jan; 26(1):83-94. PubMed ID: 23382331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012.
    Booth JN; Li J; Zhang L; Chen L; Muntner P; Egan B
    Hypertension; 2017 Aug; 70(2):275-284. PubMed ID: 28607131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
    Rosenson RS
    Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.